167 related articles for article (PubMed ID: 34836462)
41. Physiologically based kinetic models for the alkenylbenzene elemicin in rat and human and possible implications for risk assessment.
van den Berg SJ; Punt A; Soffers AE; Vervoort J; Ngeleja S; Spenkelink B; Rietjens IM
Chem Res Toxicol; 2012 Nov; 25(11):2352-67. PubMed ID: 22992039
[TBL] [Abstract][Full Text] [Related]
42. Physiologically based kinetic modeling of the bioactivation of myristicin.
Al-Malahmeh AJ; Al-Ajlouni A; Wesseling S; Soffers AE; Al-Subeihi A; Kiwamoto R; Vervoort J; Rietjens IM
Arch Toxicol; 2017 Feb; 91(2):713-734. PubMed ID: 27334372
[TBL] [Abstract][Full Text] [Related]
43. Incorporating renal excretion via the OCT2 transporter in physiologically based kinetic modelling to predict in vivo kinetics of mepiquat in rat.
Noorlander A; Wesseling S; Rietjens IMCM; van Ravenzwaay B
Toxicol Lett; 2021 Jun; 343():34-43. PubMed ID: 33639197
[TBL] [Abstract][Full Text] [Related]
44. In vitro-in silico-based prediction of inter-individual and inter-ethnic variations in the dose-dependent cardiotoxicity of R- and S-methadone in humans.
Shi M; Dong Y; Bouwmeester H; Rietjens IMCM; Strikwold M
Arch Toxicol; 2022 Aug; 96(8):2361-2380. PubMed ID: 35604418
[TBL] [Abstract][Full Text] [Related]
45. Prediction of dose-dependent in vivo acetylcholinesterase inhibition by profenofos in rats and humans using physiologically based kinetic (PBK) modeling-facilitated reverse dosimetry.
Omwenga I; Zhao S; Kanja L; Mol H; Rietjens IMCM; Louisse J
Arch Toxicol; 2021 Apr; 95(4):1287-1301. PubMed ID: 33651127
[TBL] [Abstract][Full Text] [Related]
46. Towards a systematic use of effect biomarkers in population and occupational biomonitoring.
Zare Jeddi M; Hopf NB; Viegas S; Price AB; Paini A; van Thriel C; Benfenati E; Ndaw S; Bessems J; Behnisch PA; Leng G; Duca RC; Verhagen H; Cubadda F; Brennan L; Ali I; David A; Mustieles V; Fernandez MF; Louro H; Pasanen-Kase R
Environ Int; 2021 Jan; 146():106257. PubMed ID: 33395925
[TBL] [Abstract][Full Text] [Related]
47. Assessing human internal exposure to chemicals at different physical activity levels: A physiologically based kinetic (PBK) model incorporating metabolic equivalent of task (MET).
Li Z; Zhang X
Environ Int; 2023 Dec; 182():108312. PubMed ID: 37956621
[TBL] [Abstract][Full Text] [Related]
48. Structural and functional pharmacokinetic analogs for physiologically based pharmacokinetic (PBPK) model evaluation.
Ellison CA
Regul Toxicol Pharmacol; 2018 Nov; 99():61-77. PubMed ID: 30201539
[TBL] [Abstract][Full Text] [Related]
49. In vitro to in vivo extrapolation of effective dosimetry in developmental toxicity testing: Application of a generic PBK modelling approach.
Fragki S; Piersma AH; Rorije E; Zeilmaker MJ
Toxicol Appl Pharmacol; 2017 Oct; 332():109-120. PubMed ID: 28760446
[TBL] [Abstract][Full Text] [Related]
50. Finding synergies for 3Rs - Toxicokinetics and read-across: Report from an EPAA partners' Forum.
Laroche C; Aggarwal M; Bender H; Benndorf P; Birk B; Crozier J; Dal Negro G; De Gaetano F; Desaintes C; Gardner I; Hubesch B; Irizar A; John D; Kumar V; Lostia A; Manou I; Monshouwer M; Müller BP; Paini A; Reid K; Rowan T; Sachana M; Schutte K; Stirling C; Taalman R; van Aerts L; Weissenhorn R; Sauer UG
Regul Toxicol Pharmacol; 2018 Nov; 99():5-21. PubMed ID: 30144470
[TBL] [Abstract][Full Text] [Related]
51. Tutorial on physiologically based kinetic modeling in molecular nutrition and food research.
Rietjens IM; Louisse J; Punt A
Mol Nutr Food Res; 2011 Jun; 55(6):941-56. PubMed ID: 21520492
[TBL] [Abstract][Full Text] [Related]
52. A physiologically based kinetic modeling of ethyl tert-butyl ether in humans-An illustrative application of quantitative structure-property relationship and Monte Carlo simulation.
Watanabe-Matsumoto S; Yoshida K; Meiseki Y; Ishida S; Hirose A; Yamada T
J Toxicol Sci; 2022; 47(2):77-87. PubMed ID: 35110473
[TBL] [Abstract][Full Text] [Related]
53. Towards a generic physiologically based kinetic model to predict in vivo uterotrophic responses in rats by reverse dosimetry of in vitro estrogenicity data.
Zhang M; van Ravenzwaay B; Fabian E; Rietjens IMCM; Louisse J
Arch Toxicol; 2018 Mar; 92(3):1075-1088. PubMed ID: 29234833
[TBL] [Abstract][Full Text] [Related]
54. Application of in vitro data in physiologically-based kinetic models for quantitative in vitro-in vivo extrapolation: A case-study for baclofen.
Kasteel EEJ; Lautz LS; Culot M; Kramer NI; Zwartsen A
Toxicol In Vitro; 2021 Oct; 76():105223. PubMed ID: 34293430
[TBL] [Abstract][Full Text] [Related]
55. Developing a Physiologically-Based Pharmacokinetic Model Knowledgebase in Support of Provisional Model Construction.
Lu J; Goldsmith MR; Grulke CM; Chang DT; Brooks RD; Leonard JA; Phillips MB; Hypes ED; Fair MJ; Tornero-Velez R; Johnson J; Dary CC; Tan YM
PLoS Comput Biol; 2016 Feb; 12(2):e1004495. PubMed ID: 26871706
[TBL] [Abstract][Full Text] [Related]
56. Quantitative Comparison of Avian and Mammalian Physiologies for Parameterization of Physiologically Based Kinetic Models.
Scanes CG; Witt J; Ebeling M; Schaller S; Baier V; Bone AJ; Preuss TG; Heckmann D
Front Physiol; 2022; 13():858386. PubMed ID: 35450159
[TBL] [Abstract][Full Text] [Related]
57. Development of a Generic Physiologically Based Kinetic Model to Predict In Vivo Uterotrophic Responses Induced by Estrogenic Chemicals in Rats Based on In Vitro Bioassays.
Zhang M; van Ravenzwaay B; Rietjens IMCM
Toxicol Sci; 2020 Jan; 173(1):19-31. PubMed ID: 31626307
[TBL] [Abstract][Full Text] [Related]
58. Bottom-up physiologically-based biokinetic modelling as an alternative to animal testing.
Chan JCY; Tan SPF; Upton Z; Chan ECY
ALTEX; 2019; 36(4):597-612. PubMed ID: 31079160
[TBL] [Abstract][Full Text] [Related]
59. Inter-individual variation in chlorpyrifos toxicokinetics characterized by physiologically based kinetic (PBK) and Monte Carlo simulation comparing human liver microsome and Supersome
Zhao S; Wesseling S; Rietjens IMCM; Strikwold M
Arch Toxicol; 2022 May; 96(5):1387-1409. PubMed ID: 35294598
[TBL] [Abstract][Full Text] [Related]
60. The use of in vitro toxicity data and physiologically based kinetic modeling to predict dose-response curves for in vivo developmental toxicity of glycol ethers in rat and man.
Louisse J; de Jong E; van de Sandt JJ; Blaauboer BJ; Woutersen RA; Piersma AH; Rietjens IM; Verwei M
Toxicol Sci; 2010 Dec; 118(2):470-84. PubMed ID: 20833708
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
